GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 768 filers reported holding GLAXOSMITHKLINE PLC in Q4 2017. The put-call ratio across all filers is 1.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $22,000 | -89.4% | 4,700 | -3.1% | 0.01% | -89.9% |
Q3 2019 | $207,000 | -15.9% | 4,850 | -21.1% | 0.09% | -16.0% |
Q2 2019 | $246,000 | -18.5% | 6,147 | -15.0% | 0.11% | -20.3% |
Q1 2019 | $302,000 | +7.5% | 7,232 | -1.6% | 0.13% | -2.2% |
Q4 2018 | $281,000 | -6.6% | 7,352 | -2.0% | 0.14% | +7.9% |
Q3 2018 | $301,000 | -0.3% | 7,502 | 0.0% | 0.13% | -7.4% |
Q2 2018 | $302,000 | +23.8% | 7,502 | +20.1% | 0.14% | +21.4% |
Q1 2018 | $244,000 | +18.4% | 6,245 | +7.7% | 0.11% | +24.4% |
Q4 2017 | $206,000 | -61.2% | 5,798 | -55.6% | 0.09% | -63.6% |
Q3 2017 | $531,000 | -8.0% | 13,070 | -2.2% | 0.25% | -11.5% |
Q2 2017 | $577,000 | +0.9% | 13,370 | -1.5% | 0.28% | -0.7% |
Q1 2017 | $572,000 | +10.4% | 13,570 | +0.9% | 0.28% | +4.1% |
Q4 2016 | $518,000 | -18.6% | 13,450 | -8.8% | 0.27% | -21.7% |
Q3 2016 | $636,000 | +16.1% | 14,750 | +16.6% | 0.34% | +14.6% |
Q2 2016 | $548,000 | +6.8% | 12,650 | 0.0% | 0.30% | +3.1% |
Q1 2016 | $513,000 | +2.8% | 12,650 | +2.3% | 0.29% | 0.0% |
Q4 2015 | $499,000 | – | 12,370 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |